DAVE ASPREY, founder of the supplement company Bulletproof and one of the many Silicon Valley tech titans obsessed with lengthening their life spans, famously declared he wants to live beyond 180 years. That sounds, frankly, exhausting. Yet who wouldn’t want to take a languorous sip from the gerontological cup, assuming reasonable health and fitness?
Therein lies the catch: A long life is something that’s desired and dreaded in equal measure. My uncle was a rocket scientist at NASA’s Marshall Space Flight Center in Huntsville, Alabama. When I visited him in his final years, I did not recognize this once-dynamic, brilliant man. He was confused, frail, vague. In 2014, Ezekiel Emanuel, a noted oncologist and chair of the Department of Medical Ethics and Health Policy at the University of Pennsylvania, wrote a blunt essay for The Atlantic titled “Why I Hope to Die at 75.” He argued that the “manic desperation to endlessly extend” life siphons resources and “robs us of our creativity and ability to contribute to work, society, the world.” Emanuel stands by it. “You don’t want to wait until the end of your life and live it unconsciously,” he told me recently.
45 Beauty Secrets in 5 Minutes—Here’s Everything We Learned in 2017 But what if we could change not just the expiration date but the time leading up to it? Research shows that most people are ill with disease for five to eight years before they die. Must they be? A wave of scientists is saying no.
They maintain that aging is a disease—one that can be targeted, treated, and perhaps even reversed. Longevity—a quest as old as humanity itself—is the wellness world’s latest buzzword, appearing everywhere from specialty gyms such as Longevity Lab NYC to NutriDrip’s $600 “Nutriyouth” IV formula (which promises to “turn on ‘good genes’ ”) to the Victoria Beckham–sanctioned supplements Basis NAD+. Meanwhile, big-name investors (Jeff Bezos, Peter Thiel) are backing companies that are designing drugs to stave off the impairments associated with growing old: Thiel’s Breakout Labs is intent on the modest goal of “reprogramming nature.” The longevity sector, according to some industry analysis, is on track to be a multi-trillion-dollar industry.
ONE MORNING THIS PAST SUMMER, I met Nir Barzilai, M.D., founding director of the Institute for Aging Research at the Albert Einstein College of Medicine in New York, at the entrance of the three-mile pedestrian path of the Mario Cuomo Bridge, which stretches across the Hudson River. Affable and bespectacled, the 64-year-old author of the new book Age Later has suggested we exercise during our chat—exercise is one of the magic bullets for a long and vibrant life, or “healthspan,” as he and other experts term it. (When it comes to healthspan, Barzilai says, genetics account for only some 20 percent. The rest is environment and lifestyle.) On this morning, he has not yet broken his 16-hour life-lengthening daily fast. Research has also shown that “stressors” such as intermittent fasting can prompt your body to activate the genes that help repair broken DNA and protect chromosomes.
As we walk, he takes me through his other practices: Along with his fasts and exercise, Barzilai takes a daily dose of metformin. An inexpensive diabetes medication that’s been around since the 1950s, metformin is thought to mimic the calorie restriction of fasting by limiting the amount of sugar the body absorbs (side effects are generally mild, among them abdominal pain, nausea, and loss of appetite). A 2017 study of more than 41,000 male metformin users found that it reduced—by a significant amount—the likelihood of dementia, cancer, and cardiovascular disease. A growing number of doctors are prescribing it off-label, but Barzilai wants the medication to be FDA-sanctioned for every elder adult. He’s about to undertake a six-year national trial (called TAME, for “Targeting Aging With Metformin”), partially and anonymously funded by a noted tech billionaire.
If fasting is not exactly your speed, diet is still tremendously important. As for what you should eat, the gold standard remains the Mediterranean diet—one that is high in vegetables, fruits, whole grains, beans, nuts, seeds, and olive oil, and low on red meat—the only diet, says Barzilai, proven by clinical research to decrease cardiovascular mortality. A recent study in the medical journal Gut found that following it for just one year slowed the development of age-related inflammatory processes.
Other crucial life practices: adequate sleep and stress management. In blue zones, says Buettner, “people downshift all day long, through prayer, meditation, or just taking naps.” And scientists are also coming to more fully understand the role that other people play in prolonging life. A 2019 study in the journal SSM-Population Health found that social relationships significantly increase life span in older adults. Neuroscientist Daniel Levitin, the author of this year’s Successful Aging, has found that friendships at age 80 are a bigger predictor of health than cholesterol level. Friends and even neighbors, he writes, protect your brain, while loneliness “has been implicated in just about every medical problem you can think of.”
But what about the factors you can’t control? Most of us don’t know what’s lurking in our genome and are not often aware we might inherit some disease until we see the symptoms. That is changing, with tests that are leagues beyond 23andMe. The new Preventive Genomics Clinic at Brigham and Women’s Hospital in Boston is the first academic clinic in the country to offer comprehensive DNA sequencing and interpretation of nearly 6,000 disease-associated genes, ranging from common cancers to the rare Fabry disease, which impairs fat breakdown in cells and affects the heart. “Roughly 20 percent of people will be carrying a variant for a rare disease, such as hereditary heart problems,” says director Robert Green, M.D., a medical geneticist at Brigham and Women’s. Where a full panel of tests used to cost many hundreds of thousands of dollars, the clinic charges $250 for a smaller panel and $1,900 for full sequencing and interpretation. (These costs are not yet covered by most insurance.)
“In the near future,” says Barzilai as we finish our walk, “we can be healthy and vital in our 90s and beyond.” He laughs. “It may sound like science fiction, but I promise you, it’s science.” While I can comprehend the misgivings about prolonging life, I’ll admit that I’m still programmed to crave those extra years, and will adopt what changes I can to make them more vibrant. My role model here is Gloria Steinem, now 86. “I plan to live to be 100,” she once remarked. “Which I would have to do anyway, just to meet my deadlines.”